Results 201 to 210 of about 742,813 (283)

Clearing Away the Smoke and Mirrors: Response to Dr O'Reilly [PDF]

, 2006
Steve Kisely, Leslie Anne Campbell
openalex   +1 more source

Wisdom in periodic markets and traditionally used edible & medicinal plants in Jingdong intermontane region, Southwest China. [PDF]

J Ethnobiol Ethnomed
Li Z, Zhang Q, Li F, Zeng X, Wang T, Geng Y, Chen S, Yang G, Xie C, Peng G, Zhao G, Yang F, Che S, Qu S, Liu W.   +14 more
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Are weight control and food waste a trade-off?: A clustering of pre-meal portion planning and plate-clearing behaviors among Japanese adult consumers. [PDF]

Eur J Nutr
Kawasaki Y, Nagao-Sato S, Shimpo M, Akamatsu R.   +3 more
europepmc   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Clearing the detail coefficient of 2-D DWT Architecture based on Lifting scheme of 5/3 and 9/7 Filters [PDF]

, 1999
Dhafer Al-layla
openalex   +1 more source

Immersion-Based Clearing and Autofluorescence Quenching in Myocardial Tissue. [PDF]

Microcirculation
Sturgess VE, Korovesis NK, Uceda DE, Citalan-Madrid A, Vu EV, Stangis K, Van den Bergh F, Essajee SI, Jacobovitz B, Sands GB, Lawrence DA, Tune JD, Beard DA, Murphy GG, Figueroa CA.   +14 more
europepmc   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Differences in the kinetics of optical clearing of healthy and diabetic head tissues [PDF]

Alaa Sabeeh Shanshool, Ekaterina N. Lazareva, Yury I. Surkov, Saeed Ziaee, Polina A. Dyachenko, Isabella A. Serebryakova, Daria K. Tuchina, Elina A. Genina, Valery V. Tuchin   +8 more
openalex   +1 more source

Clearing the RF smog [PDF]

, 2011
Shyamnath Gollakota, Fadel Adib, Dina Katabi, Srinivasan Seshan   +3 more
openalex   +1 more source